desoxycorticosterone has been researched along with mdl 100907 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balaraman, R; Shingala, JR | 1 |
| Abreu, GR; Bissoli, NS; Cabral, AM; Pires, JG; Ramage, AG; Silva, AL | 1 |
2 other study(ies) available for desoxycorticosterone and mdl 100907
| Article | Year |
|---|---|
Antihypertensive effect of 5-HT1A agonist buspirone and 5-HT2B antagonists in experimentally induced hypertension in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Female; Hypertension; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |
Chronic treatment with mianserin prevents DOCA-salt hypertension in rats--evidence for the involvement of central 5-HT2 receptors.
Topics: Animals; Blood Pressure; Desoxycorticosterone; Dose-Response Relationship, Drug; Drinking; Heart Rate; Hypertension; Injections, Intraventricular; Male; Mianserin; Rats; Rats, Wistar; Receptors, Serotonin, 5-HT2; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Sodium; Time Factors; Urodynamics; Weight Gain | 2005 |